secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolus, Inc. (EOLS)
CIK:        0001570562
Form:       8-K
Filed at:   2025-08-05T23:59:59+00:00
Accession:  0001570562-25-000094
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolus Q2 revenue $69.4M (+4% YoY); cuts FY2025 guidance to $295-305M; CEO appointed PFO, CMO departing
--------------------------------------------------------------------------------

- Q2 net revenue $69.4M, up 4% YoY; GAAP op loss $10.2M vs $7.7M loss YoY; non-GAAP op loss $7.9M vs $1.1M income.
- FY2025 revenue guidance reset to $295-305M (11-15% growth); non-GAAP op expenses $208-213M with $25M savings.
- Evolysse filler delivered $9.7M revenue in Q2, strongest filler launch quarter in over a decade.
- CEO David Moatazedi appointed as Principal Financial Officer; CMO Tomoko Yamagishi-Dressler departing Aug 22, no disagreement.
- Expects meaningful profitability in Q4 2025 and annual profitability from 2026; 15% Evolysse tariff minimal impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000094/0001570562-25-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1570562/000157056225000094/eols-20250801.htm
  HTML page:      https://secwatch.observer/filing/0001570562-25-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer